Echocardiography image analysis software developer DiA Imaging Analysis announced its collaboration with IBM Watson Health on artificial intelligence (AI) software.
The IBM Imaging AI Marketplace will offer DiA's U.S. Food and Drug Administration-cleared, AI-powered cardiac ultrasound software, which assists clinicians with analyzing cardiac ultrasound images automatically. IBM will introduce DiA's LVivo EF software, which offers clinicians AI-based quantification software to provide automated clinical data, such as ejection fraction (EF) and global longitudinal strain (GLS). More software will be added in the future.
